Pembrolizumab,Cisplatin,Gemcitabine,Pemetrexed,Bevacizumab,Durvalumab,Olaparib,Carboplatin,Paclitaxel
AstraZeneca,roche,Merck
['kn826', 'kn671', 'nsclc', 'duoo', 'gyn', 'ovarian', 'ts,perio,1', 'pembro', 'sclc', 'ts,perio,i', 'lcsm,(-blcsm)']
day 2 #asco23 highlights: 1. #kn671: periop pembro in resectable nsclc 2. #kn826: chemo + io in cervical ca 3. #duoo: io/parpi ovarian cancer patients in 1l #lcsm #onctwitter #medtwitter #gyncsm 1/4
Practice changing 🗣 for community oncologists: w/ Rohit Gosain @UPMCHillmanCC & Rahul Gosain @WilmotCancer. Views are our own. COI: https://t.co/cJOjp0RvQE